Terms: = Bone cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
76 results:
1. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive clinical, genome and transcriptomic analysis of primary ghost cell odontogenic carcinoma.
Zhang L; Xu Q; Feng Z
Oral Oncol; 2024 Jan; 148():106616. PubMed ID: 37988836
[TBL] [Abstract] [Full Text] [Related]
3. p300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
[TBL] [Abstract] [Full Text] [Related]
4. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
5. Efficient diagnosis of hematologic malignancies using bone marrow microscopic images: A method based on MultiPathGAN and MobileViTv2.
Yang G; Qin Z; Mu J; Mao H; Mao H; Han M
Comput Methods Programs Biomed; 2023 Jul; 237():107583. PubMed ID: 37167882
[TBL] [Abstract] [Full Text] [Related]
6. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
7. Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.
Zhang L; Zhang R; Wang J; Chen Y; Qiao C; Shi Q; Jin Y; Shen X; Li J; Chen L
Clin Epigenetics; 2022 Jul; 14(1):93. PubMed ID: 35870987
[TBL] [Abstract] [Full Text] [Related]
8. ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
Fishman H; Madiwale S; Geron I; Bari V; Van Loocke W; Kirschenbaum Y; Ganmore I; Kugler E; Rein-Gil A; Friedlander G; Schiby G; Birger Y; Strehl S; Soulier J; Knoechel B; Ferrando A; Noy-Lotan S; Nagler A; Mulloy JC; Van Vlierberghe P; Izraeli S
Blood; 2022 Jan; 139(3):399-412. PubMed ID: 34624096
[TBL] [Abstract] [Full Text] [Related]
9. Ajuba transactivates N-cadherin expression in colorectal cancer cells through interaction with Twist.
Wu Z; Zou X; Xu Y; Zhou F; Kuai R; Li J; Yang D; Chu Y; Peng H
J Cell Mol Med; 2021 Aug; 25(16):8006-8014. PubMed ID: 34173718
[TBL] [Abstract] [Full Text] [Related]
10. A novel assay for screening WIP1 phosphatase substrates in nuclear extracts.
Storchova R; Burdova K; Palek M; Medema RH; Macurek L
FEBS J; 2021 Oct; 288(20):6035-6051. PubMed ID: 33982878
[TBL] [Abstract] [Full Text] [Related]
11. Acetylation dependent functions of Rab22a-NeoF1 Fusion Protein in Osteosarcoma.
Liang X; Wang X; He Y; Wu Y; Zhong L; Liu W; Liao D; Kang T
Theranostics; 2020; 10(17):7747-7757. PubMed ID: 32685017
[No Abstract] [Full Text] [Related]
12. Dual Roles of PU.1 in the Expression of PD-L2: Direct Transactivation with IRF4 and Indirect Epigenetic Regulation.
Inaba K; Yashiro T; Hiroki I; Watanabe R; Kasakura K; Nishiyama C
J Immunol; 2020 Aug; 205(3):822-829. PubMed ID: 32611724
[TBL] [Abstract] [Full Text] [Related]
13. Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.
Zhang X; Zegar T; Lucas A; Morrison-Smith C; Knox T; French CA; Knapp S; Müller S; Siveke JT
Oncogene; 2020 Jun; 39(24):4770-4779. PubMed ID: 32366905
[TBL] [Abstract] [Full Text] [Related]
14. Chromatin accessibility promotes hematopoietic and leukemia stem cell activity.
Cabal-Hierro L; van Galen P; Prado MA; Higby KJ; Togami K; Mowery CT; Paulo JA; Xie Y; Cejas P; Furusawa T; Bustin M; Long HW; Sykes DB; Gygi SP; Finley D; Bernstein BE; Lane AA
Nat Commun; 2020 Mar; 11(1):1406. PubMed ID: 32179749
[TBL] [Abstract] [Full Text] [Related]
15. The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
Yan Y; Ma J; Wang D; Lin D; Pang X; Wang S; Zhao Y; Shi L; Xue H; Pan Y; Zhang J; Wahlestedt C; Giles FJ; Chen Y; Gleave ME; Collins CC; Ye D; Wang Y; Huang H
EMBO Mol Med; 2019 Nov; 11(11):e10659. PubMed ID: 31559706
[TBL] [Abstract] [Full Text] [Related]
16. The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription.
Jin Z; Zhou S; Ye H; Jiang S; Yu K; Ma Y
Biomed Pharmacother; 2019 Nov; 119():109434. PubMed ID: 31536933
[TBL] [Abstract] [Full Text] [Related]
17. Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
Schuldner M; Dörsam B; Shatnyeva O; Reiners KS; Kubarenko A; Hansen HP; Finkernagel F; Roth K; Theurich S; Nist A; Stiewe T; Paschen A; Knittel G; Reinhardt HC; Müller R; Hallek M; von Strandmann EP
Theranostics; 2019; 9(21):6047-6062. PubMed ID: 31534536
[TBL] [Abstract] [Full Text] [Related]
18. A CTGF-RUNX2-RANKL Axis in Breast and Prostate cancer Cells Promotes Tumor Progression in bone.
Kim B; Kim H; Jung S; Moon A; Noh DY; Lee ZH; Kim HJ; Kim HH
J Bone Miner Res; 2020 Jan; 35(1):155-166. PubMed ID: 31505052
[TBL] [Abstract] [Full Text] [Related]
19. Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease.
Zhu S; Qiu H; Bennett S; Kuek V; Rosen V; Xu H; Xu J
Cell Mol Life Sci; 2019 Nov; 76(22):4493-4502. PubMed ID: 31317206
[TBL] [Abstract] [Full Text] [Related]
20. C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin.
Katoh I; Maehata Y; Moriishi K; Hata RI; Kurata SI
Neoplasia; 2019 May; 21(5):494-503. PubMed ID: 30986748
[TBL] [Abstract] [Full Text] [Related]
[Next]
